Literature DB >> 16915376

Childhood vasculitis and plasma exchange.

Elizabeth Wright1, Michael J Dillon, Kjell Tullus.   

Abstract

INTRODUCTION: A retrospective review of therapeutic plasma exchange (TPE) for vasculitis of any form during the period 1993-2003 was carried out in our unit. SUBJECTS AND METHODS: The case histories of 32 children undergoing TPE were analysed to determine short-term outcome. The vasculitides consisted of polyarteritis nodosa (PAN), ANCA-associated vasculitis (AAV) [encompassing Wegener's granulomatosis (WG) and microscopic polyangiitis (MPA)/idiopathic crescentic nephritis (ICN)], Henoch-Schönlein purpura (HSP) and non-classified vasculitis (NCV).
RESULTS: All children with PAN (n=5) had a good response to treatment except for one with gastro-intestinal symptoms. One child was treated for crescentic nephritis, with 42% crescents seen on biopsy. The estimated glomerular filtration rate (eGFR) (Schwartz formula) for this child improved from 81 to 130 ml/min/1.73 m(2) post-treatment. Inflammatory markers decreased immediately following TPE and were maintained at the lower level for all the children. Ten children (n=12) with AAV received treatment for renal manifestations. Median creatinine clearances improved from 29 ml/min/1.73 m(2) (p<0.01) pre-treatment to 62 ml/min/1.73 m(2) (p<0.01) immediately following TPE and 69 ml/min/1.73 m(2) at 2 months post-TPE (p<0.01). Four children required dialysis; one child remained dialysis-dependent and one child progressed to chronic renal failure. Inflammatory markers decreased following TPE. All of the children with HSP (n=5) were treated for crescentic nephritis. Two regained normal renal function, and one became dialysis-dependent later. Most of the children with NCV (n=10) presented with CNS or general vasculitic features, with the greatest benefit for CNS symptoms.
CONCLUSIONS: In our experience TPE appears to be of benefit during the acute phase of illness, especially in children with organ-specific disease.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16915376     DOI: 10.1007/s00431-006-0212-2

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  16 in total

Review 1.  What is new in the therapy of ANCA-associated vasculitides? Take home messages from the 12th workshop on ANCA and systemic vasculitides.

Authors:  K de Groot; D Jayne
Journal:  Clin Nephrol       Date:  2005-12       Impact factor: 0.975

Review 2.  Nomenclature of systemic vasculitides. Proposal of an international consensus conference.

Authors:  J C Jennette; R J Falk; K Andrassy; P A Bacon; J Churg; W L Gross; E C Hagen; G S Hoffman; G G Hunder; C G Kallenberg
Journal:  Arthritis Rheum       Date:  1994-02

3.  Retrospective study of plasma exchange in patients with idiopathic rapidly progressive glomerulonephritis and vasculitis.

Authors:  A Gianviti; R S Trompeter; T M Barratt; M F Lythgoe; M J Dillon
Journal:  Arch Dis Child       Date:  1996-09       Impact factor: 3.791

4.  Clinical outcome of Schönlein-Henoch purpura nephritis in children.

Authors:  K Schärer; R Krmar; U Querfeld; H Ruder; R Waldherr; F Schaefer
Journal:  Pediatr Nephrol       Date:  1999-11       Impact factor: 3.714

Review 5.  Vasculitis in childhood.

Authors:  I Roberti; L Reisman; J Churg
Journal:  Pediatr Nephrol       Date:  1993-08       Impact factor: 3.714

6.  Plasmapheresis in the management of acute systemic lupus erythematosus?

Authors:  J V Jones; R H Cumming; R C Bucknall; C M Asplin
Journal:  Lancet       Date:  1976-04-03       Impact factor: 79.321

7.  Crescentic glomerulonephritis in children.

Authors:  H M Jardim; J Leake; R A Risdon; T M Barratt; M J Dillon
Journal:  Pediatr Nephrol       Date:  1992-05       Impact factor: 3.714

8.  Combined treatment in Wegener's granulomatosis with crescentic glomerulonephritis--clinical course and long-term outcome.

Authors:  G M Frascà; N G Zoumparidis; L C Borgnino; L Neri; L Neri; A Vangelista; V Bonomini
Journal:  Int J Artif Organs       Date:  1993-01       Impact factor: 1.595

9.  Lack of superiority of steroids plus plasma exchange to steroids alone in the treatment of polyarteritis nodosa and Churg-Strauss syndrome. A prospective, randomized trial in 78 patients.

Authors:  L Guillevin; O Fain; F Lhote; B Jarrousse; D Le Thi Huong; A Bussel; A Leon
Journal:  Arthritis Rheum       Date:  1992-02

10.  Corticosteroids plus pulse cyclophosphamide and plasma exchanges versus corticosteroids plus pulse cyclophosphamide alone in the treatment of polyarteritis nodosa and Churg-Strauss syndrome patients with factors predicting poor prognosis. A prospective, randomized trial in sixty-two patients.

Authors:  L Guillevin; F Lhote; P Cohen; B Jarrousse; O Lortholary; T Généreau; A Léon; A Bussel
Journal:  Arthritis Rheum       Date:  1995-11
View more
  12 in total

Review 1.  Pediatric vasculitis.

Authors:  Ezgi Deniz Batu; Seza Ozen
Journal:  Curr Rheumatol Rep       Date:  2012-04       Impact factor: 4.592

Review 2.  ANCA-associated vasculitides-lessons from the adult literature.

Authors:  Joannis Vamvakopoulos; Caroline O Savage; Lorraine Harper
Journal:  Pediatr Nephrol       Date:  2010-04-01       Impact factor: 3.714

3.  ANCA-associated glomerulonephritis/systemic vasculitis in childhood: clinical features-outcome.

Authors:  Ekaterini Siomou; Despoina Tramma; Claire Bowen; David V Milford
Journal:  Pediatr Nephrol       Date:  2012-05-31       Impact factor: 3.714

Review 4.  Role of therapeutic plasmapheresis in ANCA-associated vasculitis.

Authors:  Giles Walters
Journal:  Pediatr Nephrol       Date:  2015-05-19       Impact factor: 3.714

Review 5.  Vasculitis in children and adolescents: clinical presentation, etiopathogenesis, and treatment.

Authors:  Kjell Tullus; Stephen D Marks
Journal:  Paediatr Drugs       Date:  2009       Impact factor: 3.022

6.  Role of therapeutic apheresis in the treatment of pediatric kidney diseases.

Authors:  Shweta Shah; Catherine Joseph; Poyyapakkam Srivaths
Journal:  Pediatr Nephrol       Date:  2021-05-15       Impact factor: 3.714

7.  Mycophenolate mofetil treatment in two children with severe polyarteritis nodosa refractory to immunosuppressant drugs.

Authors:  Falcini Fernanda; Capannini Serena; Russo Giustina; Battagliese Antonella; D'Amico Alessandra; Maria Alessio; Alessio Maria
Journal:  Rheumatol Int       Date:  2011-07-24       Impact factor: 3.580

8.  Granulomatosis with polyangiitis: rapidly progressive necrotizing glomerulonephritis in a pediatric patient.

Authors:  Mariana Luna; Victoria Bocanegra; Patricia G Vallés
Journal:  Int J Nephrol Renovasc Dis       Date:  2014-04-23

Review 9.  Small vessel vasculitis.

Authors:  Paul Brogan; Despina Eleftheriou; Michael Dillon
Journal:  Pediatr Nephrol       Date:  2009-11-03       Impact factor: 3.714

Review 10.  Medium-size-vessel vasculitis.

Authors:  Michael J Dillon; Despina Eleftheriou; Paul A Brogan
Journal:  Pediatr Nephrol       Date:  2009-11-28       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.